About Prenuvo
Prenuvo provides whole-body MRI scans for the early detection of over 500 types of cancers and diseases, using a radiation-free and non-invasive approach. The scans are quick, taking less than an hour, and do not require contrast agents, making them safer than traditional imaging methods. Targeting health-conscious individuals, Prenuvo operates in the preventive healthcare market and generates revenue through direct-to-consumer sales of its scanning services. The company's goal is to promote proactive healthcare by encouraging early detection, which can lead to more effective treatments and reduced long-term healthcare costs.
Redwood City, CaliforniaHeadquarters
2018Year Founded
$54.5MTotal Funding
DEBTCompany Stage
Healthcare, Consumer GoodsIndustries
201-500Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Mental Health Support
Unlimited Paid Time Off
Hybrid Work Options
Risks
Increased competition from startups like Ezra could impact Prenuvo's market share.
Concerns about unnecessary costs from full-body scans may affect consumer demand.
Co-founder Dr. Raj Attariwala's transition could lead to strategic instability.
Differentiation
Prenuvo offers radiation-free, whole-body MRI scans for early disease detection.
The scans are quick, taking less than an hour, and require no contrast agents.
Prenuvo's direct-to-consumer model simplifies access to advanced diagnostic imaging.
Upsides
Recent research links Type 2 diabetes to brain aging, expanding Prenuvo's market potential.
Partnership with Turnpaugh Health enhances credibility and reach in preventative healthcare.
Mobile MRI clinics increase service accessibility, reaching underserved communities.
Funding
Total raised$54.47 M
Latest valuation$280.00 M
StageDEBT
SERIES A
9/30/2022$56
$280.00 MDEBT
9/30/2022$14